CBG, effects and studies dedicated to this cannabinoid

What is CBG, and what are CBG Effects?

A 2013 study involving mice, CBG proved to be effective in decreasing some inflammation characteristics of inflammatory bowel disease.

CBG is also showing a lot of promise in the field of cancer treatments. It has specifically been shown to block receptors that promote cancer cell growth.

In one specific study, it inhibited the growth of colorectal cancer cells in mice.

This meant that it slowed the growth of colon cancer down. CBG inhibited tumors and demonstrated the exciting possibility that colorectal cancer might one day be cured.

Research in Europe has offered evidence that CBG is an effective antibacterial agent. It is particularly efficient against methicillin-resistant Staphylococcus aureus (MRSA). Strains of MRSA are known to be resistant to a myriad of available drugs at present. 

In a 2015 study, CGB protected neurons in mice with Huntington's Disease. This disease is characterized by severe nerve cell degeneration in the brain.

Additionally, a recent 2017 study showed that a purified form of CBG with no delta-9 THC effectively stimulated appetite in rats. This could lead to the non-psychotropic treatment of cachexia, a type of muscle wasting and severe weight loss seen in late-stage cancer patients and other terminal illnesses.

Scientists are incredibly excited about these early-stage CBG findings and are actively promoting future research with CBG in combination with other cannabinoids or on its own. Unlike THC, CBG is non-psychotropic, making it potentially safe in the treatment of mental health conditions such as anxiety and depression. It also boasts analgesic properties.

For additional information, or to purchase one of our premium CBD products and start reaping the amazing benefits that cannabinoids have to offer, contact a member of the Enecta team today.

Although CBD and THC get the most attention across the world, there are at least 85 other cannabinoids present in the marijuana plant. One of these cannabinoids is called CBG.

CBG, also known as cannabigerol, is described as a minor cannabinoid because of the low amount of quantities of CBG present in most strains of cannabis. 

How Is CBG Made?

CBG is present in less than 1% in most cannabis strains, but it's a significant cannabinoid. This is because both THC and CBD begin their life as CBG.

CBG is their chemical parent. All cannabis plants produce cannabigerolic acid (CBGA), this is the precursor to the three main lines of cannabinoid: cannabidiolic acid (CBDA), cannabichromenic acid (CBCA), and tetrahydrocannabinolic acid (THCA). 

Specific enzymes in the cannabis plant break down CGBA and 'send' it towards one of these three lines. The acids are eventually exposed to ultraviolet heat or light, eventually evolving into THC and CBD.

Breeders are experimenting with genetic modification and cross-breeding of cannabis plants to obtain higher yields of CBG. Some scientists can extract high levels of CBG from plants by working out the optimum extraction time, which sits about six weeks into an eight-week flowering cycle.

CBG's Medical Effects

In the human body, the built-in endocannabinoid system (ECS) works hard to keep the body in a state of perfectly balanced homeostasis. It's already well documented that both CBD and THC have some fantastic effects when it comes to improving wellbeing and helping to alleviate certain medical conditions. However, recent studies concerning CBG have proven very promising. 

Studies Dedicated to CBG

A 2008 study shed light that CBG may be useful in the treatment of glaucoma. This is because it helps to reduce intraocular pressure. There are many endocannabinoid receptors present in the eye structures, and modern technology has given us the ability to apply topical applications to parts of the eye without causing any damage to delicate tissues. CBG has neuroprotective effects and is a potent vasodilator.